CSL (ASX:CSL) share price struggles despite new government funding

The CSL share price is lower today amid a new initiative to support biotech start-ups.

| More on:
A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in global biotech company CSL Limited (ASX: CSL) are struggling to find range today and are now inching 0.25% lower at $315.28.

Whilst there is no market sensitive information out of the blood plasma specialist's corner today, it released a statement to the media regarding an upcoming venture.

CSL will team up with Melbourne University and The Walter and Eliza Hall Institute of Medical Research (WEHI) to create an incubator and wet space lab for biotech start-ups, with support from the Victorian government.

Here are the details.

Driving world class research

CSL announced today the group has secured funding to create a start-up incubator, with the goal of supporting and growing early-stage Australian biotech companies.

Funding has been secured alongside a contribution from Breakthrough Victoria, the independent investment company administering the Victorian government's $2 billion Breakthrough Victoria Fund. 

The incubator will support start-ups by enabling them to "translate promising medical research into commercial outcomes".

In practical terms, the incubator will take on small biotech companies engaged in early research that want to take their discoveries to the next stage of development.

One factor the incubator wants to address is "skill gaps in translating research into commercial products".

Aside from "state of the art wet lab facilities", the incubator will also provide a range of services including "commercialisation education programs, facilitated access to investors, industry mentoring, and access to service providers".

Speaking on the announcement, CSL's CEO Paul Perreault said:

As one of the world's leading biotechnology companies, CSL is driven by our promise as a patient-focused organisation, so this partnership clearly aligns with our Values and Purpose. We are well positioned to support incubator residents, whose experience often lies purely within the lab, better understand commercial aspects of medicines development that may be foreign or new to them.

Why an incubator?

As CSL puts it, incubators reduce barriers to entry for start-ups. It's all about cost reduction and incubators can offer a 'one-stop shop' by minimising expenditure on things otherwise cost-prohibitive to small companies.

CSL notes start-ups that are incubated have a much higher five-year survival rate and accelerated growth trajectory compared with standalone entities.

Speaking on the announcement, WEHI director Professor Doug Hilton said the collaboration will "help to build a generation of corporate and management-skilled scientists who have the knowledge and confidence to run a successful biomed or biotech company".

The incubator is scheduled to open to start-ups in 2023 and will be able to accommodate up to 40 early-stage companies from around Australia.

CSL share price snapshot

It's been a difficult past 12 months for the CSL share price which has lost 0.09% in that time. However, this year to date it has climbed almost 12% and is up around 7% this past month.

Despite this, over the past 12 months, CSL shares have lagged the benchmark S&P/ASX 200 Index (ASX: XJO).

The  author Zach Bristow has no positions in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

Young girl drinking milk showing off muscles.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a great end to the trading week for ASX investors today.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Share Gainers

3 ASX 200 stocks smashing the benchmark this week

These three ASX 200 stocks are leading the charge this week. Here’s how.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why A2 Milk, EOS, GQG, and Mineral Resources shares are racing higher today

These shares are ending the week strongly. But why?

Read more »

A man wearing a red jacket and mountain hiking clothes stands at the top of a mountain peak and looks out over countless mountain ranges.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another disappointing day for ASX investors this Thursday.

Read more »

two men smiling with a laptop in front of them, symbolising a rising share price.
Share Gainers

Why Pinnacle, PWR, Race Oncology, and Vulcan shares are flying today

These shares are having a good session on Thursday. But why?

Read more »

A beautiful woman holds up one finger with one hand and has her hand on her waist with the other as she smiles widely as though she is very pleased about something.
Share Gainers

Why Boss Energy, Emeco, Mineral Resources, and Plenti shares are pushing higher today

These shares are having a good time on hump day. But why?

Read more »

Three small children reach up to hold a toy rocket high above their heads in a green field with a blue sky above them.
Share Gainers

3 ASX 300 shares going gangbusters on Wednesday

Investors are bidding up these three ASX 300 shares today. But why?

Read more »

Man raising both his arms in the air with a piggy bank on his lap, symbolising a record high.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a huge Tuesday for ASX shares, with the index resetting its record high.

Read more »